The quarter missed the key top-line bar. Wall Street expected roughly $2.46 billion of revenue and $1.79 of EPS; lululemon delivered $2.416 billion of revenue, about 2% below consensus, while comparable sales fell 10% in constant dollars. The EPS headline is misleading because it included a one-time tariff benefit.
| Metric | Q2 2026 | Q2 2025 | Market expectation / change |
|---|---|---|---|
| Net revenue | $2.416B | $2.525B | ~$2.46B consensus |
| Diluted EPS | $2.92 | $3.10 | ~$1.79 consensus, including $0.86 tariff benefit |
| Comparable sales, constant dollars | -10% | — | — |
| Gross margin | 60.5% | 58.5% | — |
| Operating margin | 18.8% | 20.7% | — |
| FY2026 revenue outlook | $10.35B-$10.50B | — | Prior: $11.00B-$11.15B |
| FY2026 EPS outlook | $9.48-$9.73 | — | Prior: $10.95-$11.15 |
The EPS beat was largely artificial. The $2.92 diluted EPS included $0.86 per share from tariff refunds and related interest, implying roughly $2.06 before that benefit—still above the published consensus, but far less impressive than the headline suggests. The refund also reduced cost of goods sold, lifting gross margin to 60.5% even as underlying demand weakened. 〔0〕
Underlying profitability deteriorated despite the refund. Revenue declined 4% overall and 5% in constant dollars, while operating income fell 13% and operating margin narrowed to 18.8% from 20.7%. Selling, general and administrative expenses rose to 41.7% of revenue from 37.7%, showing that cost pressure and investment were outpacing the shrinking sales base. (Income Statement)
The full-year reset is the real negative surprise. Management cut the revenue outlook midpoint by about $650 million, or roughly 6%, from its June forecast, and cut the EPS midpoint by about $1.45 even after adding the $0.86 tariff benefit. The new forecast now calls for a 5%-7% revenue decline, a materially worse trajectory than the prior outlook for roughly flat sales.
The market’s concern has shifted from a soft quarter to a reset growth story. North America comparable sales declined 12% in constant dollars, while international comparable sales also fell 6%; international reported revenue growth was helped by expansion rather than healthy established-store demand. Management is increasing marketing and product investment, but the filing offers no near-term evidence that those actions will reverse the deterioration. 〔1〕
Read the original 8-K on SEC EDGAR ↗